RELISTOR 12 mg in 0.6 mL Injection
RxNorm 979115
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 979115 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: RELISTOR 12 mg in 0.6 mL Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
0.6 mL methylnaltrexone bromide 20 mg/ML Injection [Relistor]
(Atom ID: 12361487)
SYPrescribable
Synonym (SY):
0.6 mL Relistor 20 mg/ML Injection
(Atom ID: 7255381)
PSNPrescribable
Prescribable Name (PSN):
RELISTOR 12 mg in 0.6 mL Injection
(Atom ID: 7255380)
SYPrescribable
Synonym (SY):
Relistor 12 mg per 0.6 mL Injection
(Atom ID: 7255382)
Patient Education
Methylnaltrexone Injection
Methylnaltrexone injection is used to treat constipation caused by opioid (narcotic) pain medications in people with chronic (on-going) pain that is not caused by cancer but may be related to a previous cancer or cancer treatment. It is also used to treat constipation caused by opioid pain medications in people with an advanced illness or for active cancer pain. Methylnaltrexone injection is in a class of medications called peripherally acting mu-opioid receptor antagonists. It works by protecting the bowel from the effects of opioid (narcotic) medications.
[Learn More]
* Please review the disclaimer below.